MoneyWorks4Me

Phaarmasia - Quaterly Results

25 May 2023 Evaluate
An increase of about 80.19% to Rs. 75.03 millions in the topline was observed for the quarter ended March 2023. The topline stood at Rs. 41.64 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2023 is Rs. -0.93 millions as compared to Net Loss of Rs. -1.49 millions of corresponding quarter ended March 2022 Operating profit Margin for the quarter ended March 2023 further decreased to -0.69% as compared to -0.80% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 75.03 41.64 80.19 274.90 172.16 59.68 274.90 172.16 59.68
Other Income 1.41 1.54 -8.44 5.16 4.70 9.79 5.16 4.70 9.79
PBIDT -0.69 -0.80 -13.75 -10.27 -12.65 -18.81 -10.27 -12.65 -18.81
Interest 0.32 0.01 3100.00 0.45 0.04 1025.00 0.45 0.04 1025.00
PBDT -1.01 -0.81 24.69 -10.72 -12.69 -15.52 -10.72 -12.69 -15.52
Depreciation 1.70 0.72 136.11 3.60 2.92 23.29 3.60 2.92 23.29
PBT -2.71 -1.53 77.12 -14.32 -15.61 -8.26 -14.32 -15.61 -8.26
TAX -1.78 -0.04 4350.00 -1.73 -0.15 1053.33 -1.73 -0.15 1053.33
Deferred Tax -1.78 -0.04 4350.00 -1.73 -0.15 1053.33 -1.73 -0.15 1053.33
PAT -0.93 -1.49 -37.58 -12.59 -15.46 -18.56 -12.59 -15.46 -18.56
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) -0.92 -1.92 -52.13 -3.74 -7.35 -49.16 -3.74 -7.35 -49.16
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..